Rowana Ruiz
Analyst, LeRinc
Replay available
United Therapeutics Corporation (UTHR) Q3 2025 Earnings Call
United Therapeutics Corporation (NASDAQ: UTHR) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Harry Silvers
Investor Relations Manager, United Therapeutics Corporation
Dr. Martine Rothblatt
Chairperson and Chief Executive Officer, United Therapeutics Corporation
Michael Benkowitz
President and Chief Operating Officer, United Therapeutics Corporation
Dr. Lee Peterson
Executive Vice President of Product Development and Xenotransplantation, United Therapeutics Corporation
Pat Plassant
Executive Vice President for Technical Operations, United Therapeutics Corporation
Lisa Walter
Analyst, RBC Capital Markets
Andreas Aggerides
Analyst, Oppenheimer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for United Therapeutics Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.856 Good morning, everyone, and welcome to the United Therapeutics Corporation third quarter 00:00:03.856 -- 00:00:10.004 2025 corporate update. My name is Jamie, and I will be your conference operator today. 00:00:10.004 -- 00:00:14.410 All participants on the call portion of this webcast will be in a listen-only mode until 00:00:14.410 -- 00:00:17.534 the question and answer portion of this earnings call. 00:00:17.534 -- 00:00:22.461 If you'd like to ask a question during that time, please press star and the number one 00:00:22.461 -- 00:00:26.626 on your telephone keypads. If you'd like to withdraw your questions, you may press star 00:00:26.626 -- 00:00:29.866 and the number two on your telephone keypads. 00:00:29.866 -- 00:00:33.070 Please also note today's event is being recorded. 00:00:33.070 -- 00:00:37.454 At this time, I'd like to turn the floor over to Harry Silvers, Investor Relations Manager 00:00:37.454 -- 00:00:39.935 at United Therapeutics. 00:00:40.418 -- 00:00:44.502 Thank you, Jamie. Good morning. It is my pleasure to welcome you to the United Therapeutics 00:00:44.502 -- 00:00:49.788 Corporation third quarter 2025 corporate update webcast. 00:00:49.788 -- 00:00:54.533 Remarks today will include forward-looking statements representing our expectations or 00:00:54.533 -- 00:00:59.544 beliefs regarding future events. These statements involve risks and uncertainties that 00:00:59.544 -- 00:01:02.687 may cause actual results to differ materially. 00:01:02.687 -- 00:01:08.314 Our latest SEC filings, including forms 10-K and 10-Q, contain additional information 00:01:08.314 -- 00:01:14.619 on these risks and uncertainties. We assume no obligation to update forward-looking statements. 00:01:14.661 -- 00:01:19.466 Today's re...